tepoxalin has been researched along with sq-23377 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kazmi, SM; Lau, CY; Plante, RK; Taylor, GR; Visconti, V; Zhou, L | 1 |
Argentieri, D; Barbone, AG; Lau, CY; Ritchie, D; Wang, EY; Zhou, L | 1 |
2 other study(ies) available for tepoxalin and sq-23377
Article | Year |
---|---|
Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cell Line; Chloramphenicol O-Acetyltransferase; Cyclooxygenase Inhibitors; DNA Primers; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Interleukin-6; Ionomycin; Kinetics; Lipoxygenase Inhibitors; Mice; Molecular Sequence Data; Naproxen; NF-kappa B; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Proto-Oncogene Proteins c-myc; Pyrazoles; Recombinant Proteins; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured | 1995 |
Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Topics: Base Sequence; Cell Line; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-2; Ionomycin; Lymphocyte Activation; Molecular Sequence Data; Muromonab-CD3; Polymerase Chain Reaction; Pyrazoles; Receptors, Interleukin-2; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate | 1994 |